Vie Ventures
Bridging venture capital and disease philanthropy
to develop breakthrough therapies
Vie Ventures operates at the intersection of venture capital and disease philanthropy.
Our team leverages decades of experience, a proven track record in life sciences venture capital, a returns-oriented approach, and a network of strategic collaborators from across the biotech and disease philanthropy ecosystems to advance life-changing therapies and cures for patients.
Celebrating the Discovery of Regulatory T Cells
A Panel Discussion About Our Strategy
Latest News
Jan 21, 2026
Interview with Vie Ventures Co-Founders Dr. Steven St. Peter and Dr. Luke Evnin and Senior Advisor Dr. Louis DeGennaro
Jan 5, 2026
Catalytic Capital in Biotech & VC Philanthropy: Redefining purpose-aligned capital in biotech
Dec 5, 2025
Two veterans from MPM have launched a new VC firm, Vie Ventures, that will focus on investing in the I&I space – and it will leverage collaborations with disease specific philanthropies
Dec 2, 2025
A Venture Fund that Leverages Patient Experts to Target Autoimmune Diseases (RARECast)
Sep 17, 2025
Vie Ventures Convenes Inaugural Therapeutics Advisory Council to Advance Collaboration Among Autoimmune Disease Ecosystems
Sep 16, 2025